(MedPage Today) — Coverage denials for prescription drugs have increased among major insurers, according to a review of 4 billion claims. (New York Times)
The FDA decided that results of a clinical trial of the virus-derived RP1 (vusolimogene…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116676
Author :
Publish date : 2025-07-25 17:10:00
Copyright for syndicated content belongs to the linked Source.
